Turn Therapeutics Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▲ +157.5% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| IMRXImmuneering Corp | $4.61 | — | 1.6x | — | -52.15% | $298.26M |
| TLSITriSalus Life Sciences, Inc. | $4.83 | — | 45.1x | — | — | $297.41M |
| CVCapsoVision, Inc | $5.93 | — | 22.5x | — | -335.06% | $296.78M |
| TMCITreace Medical Concepts Inc | $4.65 |
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Company description provided by Yahoo Finance.
| — |
| 4.5x |
| — |
| -71.99% |
| $302.41M |
| AMRNAmarin Corp Plc\uk | $13.97 | — | 0.7x | — | -5.97% | $295.09M |
| VNDAVanda Pharmaceuticals Inc. | $5.04 | — | 1.1x | — | -77.81% | $304.73M |